amoxicillin dosage 250 mg per 5ml
(Reuters) – AbbVie Inc and Eli Lilly & Co are facing fresh delays in the approval of their respective rheumatoid arthritis drugs for treating the chronic skin disease eczema as the U.S. health regulator assesses the new class of treatment over safety concerns. The treatment, called JAK inhibitors, blocks inflammation-causing enzymes known as Janus kinases and targets a range of […]
Continue reading »